|
|
Review |
| Molecular control of cell cycle progression in primary human hematopoietic stem cells: methods to increase levels of retroviral-mediated transduction |
1473 |
| MA Dao & JA Nolta
|
|
Abstract
Full Article (PDF)
|
|
Original Manuscripts |
| Therapy |
| Has the prognosis of adult patients with acute myeloid leukemia improved over years? A single institution experience of 784 consecutive patients over a 16-year period |
1481 |
| M Baudard,
A Beauchamp-Nicoud,
A Delmer,
B Rio,
CM Blanc,
R Zittoun & JP Marie
|
|
Abstract
Full Article (PDF)
|
|
| A phase II trial of induction and consolidation therapy of acute myeloid leukemia with weekly oral idarubicin alone in poor risk elderly patients |
1491 |
| R Bouabdallah,
F Lefrère,
C Rose,
P Chaïbi,
J-L Harousseau,
J-P Vernant,
S Castaigne,
F Bauduer,
J-M Zini,
D Coso,
B Varet,
J Robert & P Fenaux
|
|
Abstract
Full Article (PDF)
|
|
| Chronic Lymphocytic Leukemia |
| Linkage analysis for ATM in familial B cell chronic lymphocytic leukaemia |
1497 |
| S Bevan,
D Catovsky,
A Marossy,
E Matutes,
S Popat,
P Antonovic,
A Bell,
A Berrebi,
EJ Gaminara,
K Quabeck,
I Ribeiro,
FR Mauro,
P Stark,
H Sykes,
J van Dongen,
J Wimperis,
S Wright,
MR Yuille & RS Houlston
|
|
Abstract
Full Article (PDF)
|
|
| CD79b expression in B cell chronic lymphocytic leukemia: its implication for minimal residual disease detection |
1501 |
| JA Garcia Vela,
I Delgado,
L Benito,
MC Monteserin,
L Garcia Alonso,
N Somolinos,
MA Andreu & F Oña
|
|
Abstract
Full Article (PDF)
|
|
| Minimally Differentiated Acute Leukemia |
| Minimally differentiated acute myeloid leukemia in Taiwan: predominantly occurs in children less than 3 years and adults between 51 and 70 years |
1506 |
| S-Y Huang,
J-L Tang,
S-T Jou,
W Tsay,
C-H Hu,
D-T Lin,
K-S Lin,
K-S Lin,
C-H Wang,
Y-C Chen,
M-C Shen & H-F Tien
|
|
Abstract
Full Article (PDF)
|
|
| The immunophenotype of minimally differentiated acute myeloid leukemia (AML-M0): reduced immunogenicity and high frequency of CD34+/CD38- leukemic progenitors |
1513 |
| RT Costello,
F Mallet,
H Chambost,
D Sainty,
C Arnoulet,
J-A Gastaut & D Olive
|
|
Abstract
Full Article (PDF)
|
|
| Minimal Residual Disease |
| Monitoring of minimal residual leukemia in patients with MLL-AF9 positive acute myeloid leukemia by RT-PCR |
1519 |
| G Mitterbauer,
C Zimmer,
C Fonatsch,
OA Haas,
R Thalhammer-Scherrer,
I Schwarzinger,
P Kalhs,
U Jaeger,
K Lechner & C Mannhalter
|
|
Abstract
Full Article (PDF)
|
|
| Molecular Cytogenetics |
| The leukemogenic fusion of MLL with ENL creates a novel transcriptional transactivator |
1525 |
| SA Schreiner,
MP García-Cuéllar,
GH Fey & RK Slany
|
|
Abstract
Full Article (PDF)
|
|
| Identification of novel chromosomal rearrangements in acute myelogenous leukemia involving loci on chromosome 2p23, 15q22 and 17q21 |
1534 |
| A Melnick,
S Fruchtman,
A Zelent,
M Liu,
Q Huang,
B Boczkowska,
MJ Calasanz,
A Fernandez,
JD Licht & V Najfeld
|
|
Abstract
Full Article (PDF)
|
|
| Apoptosis |
Regulation of CD95 expression and CD95-mediated cell death by interferon- in acute lymphoblastic leukemia with chromosomal translocation t(4;11) |
1539 |
| J Dörrie,
W Schuh,
A Keil,
E Bongards,
J Greil,
GH Fey & SJ Zunino
|
|
Abstract
Full Article (PDF)
|
|
| Quantitative analysis detects ubiquitous expression of apoptotic regulators in B cell non-Hodgkin’s lymphomas |
1548 |
| L Xerri,
E Devilard,
R Bouabdallah,
J Hassoun,
L Chaperot,
F Birg & J Plumas
|
|
Abstract
Full Article (PDF)
|
|
| Apoptosis in patients with myelodysplastic syndromes: differential involvement of marrow cells in ‘good’ versus ‘poor’ prognosis patients and correlation with apoptosis-related genes |
1554 |
| P Tsoplou,
A Kouraklis-Symeonidis,
E Thanopoulou,
P Zikos,
V Orphanos & NC Zoumbos
|
|
Abstract
Full Article (PDF)
|
|
| Bryostatin 1 enhances paclitaxel-induced mitochondrial dysfunction and apoptosis in human leukemia cells (U937) ectopically expressing Bcl-xL |
1564 |
| S Wang,
Z Wang,
LH Boise,
P Dent & S Grant
|
|
Abstract
Full Article (PDF)
|
|
| Bcl-2 family members in childhood acute lymphoblastic leukemia: relationships with features at presentation, in vitro and in vivo drug response and long-term clinical outcome |
1574 |
| GS Salomons,
LA Smets,
M Verwijs-Janssen,
AAM Hart,
EG Haarman,
GJL Kaspers,
ER Van Wering,
A Van Der Does-Van Den Berg & WA Kamps
|
|
Abstract
Full Article (PDF)
|
|
| Perillyl alcohol selectively induces G0/G1 arrest and apoptosis in Bcr/Abl-transformed myeloid cell lines |
1581 |
| MB Sahin,
SM Perman,
G Jenkins & SS Clark
|
|
Abstract
Full Article (PDF)
|
|
| Lymphoma |
| Cytogenetic analysis of the bipotential murine pre-B cell lymphoma, P388, and its derivative macrophage-like tumor, P388D1, using SKY and CGH |
1592 |
| AE Coleman,
ST Forest,
N McNeil,
AL Kovalchuk,
T Ried & S Janz
|
|
Abstract
Full Article (PDF)
|
|
Open Forum |
| False human hematopoietic cell lines: cross-contaminations and misinterpretations |
1601 |
| HG Drexler,
WG Dirks & RAF MacLeod
|
|
Abstract
Full Article (PDF)
|
|
Bio-Technical Methods Section (BTS) |
| Genetic manipulation of primitive leukemic and normal hematopoietic cells using a novel method of adenovirus-mediated gene transfer |
1608 |
| DS Howard,
DA Rizzierri,
B Grimes,
D Upchurch,
GL Phillips,
AK Stewart,
JR Yannelli & CT Jordan
|
|
Abstract
Full Article (PDF)
|
|
Identification of false-positive CBF /MYH11 RT-PCR results |
1617 |
| SM Hackwell,
DO Robinson,
JF Harvey & FM Ross
|
|
Abstract
Full Article (PDF)
|
|
| Easy detection of all T cell receptor gamma (TCRG) gene rearrangements by Southern blot analysis: recommendations for optimal results |
1620 |
| EJ Moreau,
AW Langerak,
EJ van Gastel-Mol,
ILM Wolvers-Tettero,
M Zhan,
Q Zhou,
BF Koop & JJM van Dongen
|
|
Abstract
Full Article (PDF)
|
|
Brief Communications |
| Testing for tumor drug resistance in the age of molecular medicine. A contribution to the Debate Round-Table on phenotypic and genotypic analyses of multidrug resistance (MDR) in clinical hospital practice |
1627 |
| T Efferth
|
|
Abstract
Full Article (PDF)
|
|
| Exclusion of Leu1 and Leu2 genes as tumor suppressor genes in 13q14.3-deleted B-CLL |
1630 |
| G Rondeau,
I Moreau,
S Bézieau,
E Cadoret,
J-P Moisan & M-C Devilder
|
|
Abstract
Full Article (PDF)
|
|
Correspondence |
| Significantly lower relapse rate for TEL/AML1-positive ALL |
1633 |
J Zuna,
O Hru ak,
M Kalinová,
K Mu íková,
J Starý & J Trka for the Czech Paediatric Haematology Working Group
|
|
Full Article (PDF)
|
|
| Vascular endothelial growth factor at high plasma levels is associated with extranodal involvement in adult T cell leukemia patients |
1634 |
| T Hayashibara,
T Fujimoto,
T Miyanishi,
Y Yamada,
T Maita,
S Kamihira & M Tomonaga
|
|
Full Article (PDF)
|
|
| Translisin recognition site sequences flank translocation breakpoints in a Philadelphia chromosome positive chronic myeloid leukemia patient expressing a novel type of chimeric BCR-ABL transcript (E8-INT-A2) |
1635 |
| G Martinelli,
C Terragna,
M Amabile,
V Montefusco,
N Testoni,
E Ottaviani,
A de Vivo,
A Mianulli,
E Trabacchi,
G Saglio & S Tura
|
|
Full Article (PDF)
|
|
| Waldenström’s macroglobulinemia is a biological syndrome which may occur during the evolution of different types of low grade B cell lymphoma |
1637 |
| J Diebold,
T Molina,
F Tissier,
A le Tourneau & J Audouin
|
|
Full Article (PDF)
|
|
